Mark McDade, Director at Tourmaline Bio, Inc. (TRML), bought 100,000 shares at $32.50 ($3.3M) on 2024-01-29, disclosed to the SEC on 2024-01-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| PrivatePHILLIPS EDISON GROCERY CENTER REIT II, INC. | BUY | 2015-07-17 | $9K | — | Filing → |
| PrivatePHILLIPS EDISON GROCERY CENTER REIT II, INC. | BUY | 2015-05-08 | $9K | — | Filing → |
| PDLI | SELL | 2007-01-19 | $215K | — | Filing → |